Ignite Creation Date:
2024-05-06 @ 7:39 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06088264
Status:
COMPLETED
Last Update Posted:
2024-03-29
First Post:
2023-10-12
Brief Title:
A Study to Evaluate the Drug Levels Metabolism and Removal of BMS-986322 in Healthy Adult Male Participants
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Study Overview
Official Title:
A Phase 1 Single-center Open-label Study to Evaluate the Pharmacokinetics Metabolism and Excretion of 14C BMS-986322 in Healthy Adult Male Participants
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the drug levels metabolism and removal of BMS-986322 in healthy adult male participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None